Intellectual Property India Publishes Patent Application for A Platform For Autologous Transplantable Human Skin Constructs With Coupled Mechanical Stress Buffering, Tamper-Evident Evidence Ledger, Mandatory Clinical Safety Gates, And Long-Term Integration Governance

MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202611004888 A) filed by Dr Vasudhesh Vijay; and Vijashay Biofabrication Private Limited on January 18, 2026, for A Platform For Autologous Transplantable Human Skin Constructs With Coupled Mechanical Stress Buffering, Tamper-Evident Evidence Ledger, Mandatory Clinical Safety Gates, And Long-Term Integration Governance.

Inventor includes Dr Vasudhesh Vijay.

The application for the patent was published on July 31, 2026, under issue no. 31/2026.

Abstract: A platform for autologous transplantable human skin constructs is disclosed, comprising a living biological skin layer and a temporary mechanical stress buffering layer deployed as a coupled composite unit to improve early integration reliability. The platform includes mandatory clinical safety gates prohibiting release unless predetermined risk criteria are satisfied, and a tamper-evident evidence ledger binding chain-of-identity, chain-of-custody, release metrics, deviation closure, and post- deployment surveillance. The platform supports distributed manufacturing entities while maintaining audit-ready evidence continuity.

Disclaimer: Curated by HT Syndication.